Skip to main content
Erschienen in: European Journal of Clinical Microbiology & Infectious Diseases 9/2013

01.09.2013 | Article

Streptococcus bovis/Streptococcus equinus complex fecal carriage, colorectal carcinoma, and infective endocarditis: a new appraisal of a complex connection

verfasst von: C. Chirouze, I. Patry, X. Duval, V. Baty, P. Tattevin, T. Aparicio, M. Pagenault, F. Carbonnel, G. Couetdic, B. Hoen

Erschienen in: European Journal of Clinical Microbiology & Infectious Diseases | Ausgabe 9/2013

Einloggen, um Zugang zu erhalten

Abstract

The proportion of group D streptococcal infective endocarditis (IE) (predominantly due to Streptococcus gallolyticus) and the incidence of colorectal cancer are higher in France than in most European countries. We assumed that this could be explained by a high group D streptococci (GDS) fecal carriage rate. The aims of this study were to re-assess the GDS fecal carriage rate in France and its relationship with colorectal cancer. Consecutive adult subjects who were to undergo a complete colonoscopy were invited to participate. GDS were searched in subjects’ stools before their colonoscopy using biomolecular techniques. Colonoscopic findings were sorted into four subgroups: normal colonoscopy, non-tumoral lesions, benign tumors, and premalignant/malignant tumors. GDS fecal carriages were calculated overall and in each subgroup and compared. The data from 259 subjects were analyzed. GDS were identified in the feces of 12 subjects, with the following distribution: S. lutetiensis (n = 9), S. pasteurianus (n = 2), and S. gallolyticus (n = 1). This accounted for an overall GDS fecal carriage rate of 4.6 %. The GDS fecal carriage rate was 6 % in case of normal colonoscopy, 1.3 % in case of non-tumoral lesions, 3.2 % in case of benign tumors, and 11 % in case of premalignant/malignant tumors. These four percentages were not statistically different. The GDS fecal carriage rate was lower than expected, which did not confirm our working hypothesis. Most strains belonged to S. bovis biotype II, while S. gallolyticus was found only once. These findings suggest that different GDS play different roles in the etiopathogenesis of IE and colorectal cancer.
Literatur
1.
Zurück zum Zitat Klein RS, Recco RA, Catalano MT et al (1977) Association of Streptococcus bovis with carcinoma of the colon. N Engl J Med 297:800–802PubMedCrossRef Klein RS, Recco RA, Catalano MT et al (1977) Association of Streptococcus bovis with carcinoma of the colon. N Engl J Med 297:800–802PubMedCrossRef
2.
Zurück zum Zitat Klein RS, Catalano MT, Edberg SC et al (1979) Streptococcus bovis septicemia and carcinoma of the colon. Ann Intern Med 91:560–562PubMedCrossRef Klein RS, Catalano MT, Edberg SC et al (1979) Streptococcus bovis septicemia and carcinoma of the colon. Ann Intern Med 91:560–562PubMedCrossRef
3.
Zurück zum Zitat Hoen B, Briançon S, Delahaye F et al (1994) Tumors of the colon increase the risk of developing Streptococcus bovis endocarditis: case–control study. Clin Infect Dis 19:361–362PubMedCrossRef Hoen B, Briançon S, Delahaye F et al (1994) Tumors of the colon increase the risk of developing Streptococcus bovis endocarditis: case–control study. Clin Infect Dis 19:361–362PubMedCrossRef
4.
Zurück zum Zitat Schlegel L, Grimont F, Ageron E et al (2003) Reappraisal of the taxonomy of the Streptococcus bovis/Streptococcus equinus complex and related species: description of Streptococcus gallolyticus subsp. gallolyticus subsp. nov., S. gallolyticus subsp. macedonicus subsp. nov. and S. gallolyticus subsp. pasteurianus subsp. nov. Int J Syst Evol Microbiol 53:631–645PubMedCrossRef Schlegel L, Grimont F, Ageron E et al (2003) Reappraisal of the taxonomy of the Streptococcus bovis/Streptococcus equinus complex and related species: description of Streptococcus gallolyticus subsp. gallolyticus subsp. nov., S. gallolyticus subsp. macedonicus subsp. nov. and S. gallolyticus subsp. pasteurianus subsp. nov. Int J Syst Evol Microbiol 53:631–645PubMedCrossRef
5.
Zurück zum Zitat Leclercq R, Huet C, Picherot M et al (2005) Genetic basis of antibiotic resistance in clinical isolates of Streptococcus gallolyticus (Streptococcus bovis). Antimicrob Agents Chemother 49:1646–1648PubMedCrossRef Leclercq R, Huet C, Picherot M et al (2005) Genetic basis of antibiotic resistance in clinical isolates of Streptococcus gallolyticus (Streptococcus bovis). Antimicrob Agents Chemother 49:1646–1648PubMedCrossRef
6.
Zurück zum Zitat Habib G, Hoen B, Tornos P et al (2009) Guidelines on the prevention, diagnosis, and treatment of infective endocarditis (new version 2009): the Task Force on the Prevention, Diagnosis, and Treatment of Infective Endocarditis of the European Society of Cardiology (ESC). Endorsed by the European Society of Clinical Microbiology and Infectious Diseases (ESCMID) and the International Society of Chemotherapy (ISC) for Infection and Cancer. Eur Heart J 30:2369–2413PubMedCrossRef Habib G, Hoen B, Tornos P et al (2009) Guidelines on the prevention, diagnosis, and treatment of infective endocarditis (new version 2009): the Task Force on the Prevention, Diagnosis, and Treatment of Infective Endocarditis of the European Society of Cardiology (ESC). Endorsed by the European Society of Clinical Microbiology and Infectious Diseases (ESCMID) and the International Society of Chemotherapy (ISC) for Infection and Cancer. Eur Heart J 30:2369–2413PubMedCrossRef
7.
Zurück zum Zitat Burns CA, McCaughey R, Lauter CB (1985) The association of Streptococcus bovis fecal carriage and colon neoplasia: possible relationship with polyps and their premalignant potential. Am J Gastroenterol 80:42–46PubMed Burns CA, McCaughey R, Lauter CB (1985) The association of Streptococcus bovis fecal carriage and colon neoplasia: possible relationship with polyps and their premalignant potential. Am J Gastroenterol 80:42–46PubMed
8.
Zurück zum Zitat Gold JS, Bayar S, Salem RR (2004) Association of Streptococcus bovis bacteremia with colonic neoplasia and extracolonic malignancy. Arch Surg 139:760–765PubMedCrossRef Gold JS, Bayar S, Salem RR (2004) Association of Streptococcus bovis bacteremia with colonic neoplasia and extracolonic malignancy. Arch Surg 139:760–765PubMedCrossRef
9.
Zurück zum Zitat Abdulamir AS, Hafidh RR, Mahdi LK et al (2009) Investigation into the controversial association of Streptococcus gallolyticus with colorectal cancer and adenoma. BMC Cancer 9:403PubMedCrossRef Abdulamir AS, Hafidh RR, Mahdi LK et al (2009) Investigation into the controversial association of Streptococcus gallolyticus with colorectal cancer and adenoma. BMC Cancer 9:403PubMedCrossRef
10.
Zurück zum Zitat Al-Jashamy K, Murad A, Zeehaida M et al (2010) Prevalence of colorectal cancer associated with Streptococcus bovis among inflammatory bowel and chronic gastrointestinal tract disease patients. Asian Pac J Cancer Prev 11:1765–1768PubMed Al-Jashamy K, Murad A, Zeehaida M et al (2010) Prevalence of colorectal cancer associated with Streptococcus bovis among inflammatory bowel and chronic gastrointestinal tract disease patients. Asian Pac J Cancer Prev 11:1765–1768PubMed
11.
Zurück zum Zitat Abdulamir AS, Hafidh RR, Bakar FA (2010) Molecular detection, quantification, and isolation of Streptococcus gallolyticus bacteria colonizing colorectal tumors: inflammation-driven potential of carcinogenesis via IL-1, COX-2, and IL-8. Mol Cancer 9:249PubMedCrossRef Abdulamir AS, Hafidh RR, Bakar FA (2010) Molecular detection, quantification, and isolation of Streptococcus gallolyticus bacteria colonizing colorectal tumors: inflammation-driven potential of carcinogenesis via IL-1, COX-2, and IL-8. Mol Cancer 9:249PubMedCrossRef
12.
Zurück zum Zitat Garza-González E, Ríos M, Bosques-Padilla FJ et al (2012) Immune response against Streptococcus gallolyticus in patients with adenomatous polyps in colon. Int J Cancer 131:2294–2299PubMedCrossRef Garza-González E, Ríos M, Bosques-Padilla FJ et al (2012) Immune response against Streptococcus gallolyticus in patients with adenomatous polyps in colon. Int J Cancer 131:2294–2299PubMedCrossRef
13.
Zurück zum Zitat Dubrow R, Edberg S, Wikfors E et al (1991) Fecal carriage of Streptococcus bovis and colorectal adenomas. Gastroenterology 101:721–725PubMed Dubrow R, Edberg S, Wikfors E et al (1991) Fecal carriage of Streptococcus bovis and colorectal adenomas. Gastroenterology 101:721–725PubMed
14.
Zurück zum Zitat Potter MA, Cunliffe NA, Smith M et al (1998) A prospective controlled study of the association of Streptococcus bovis with colorectal carcinoma. J Clin Pathol 51:473–474PubMedCrossRef Potter MA, Cunliffe NA, Smith M et al (1998) A prospective controlled study of the association of Streptococcus bovis with colorectal carcinoma. J Clin Pathol 51:473–474PubMedCrossRef
15.
Zurück zum Zitat Huang C-C, Chang S-C, Shen M-H et al (2008) Streptococcus bovis fecal carriage is not associated with an increased risk of colorectal neoplasm. J Soc Colon Rectal Surgeon 19:71–77 Huang C-C, Chang S-C, Shen M-H et al (2008) Streptococcus bovis fecal carriage is not associated with an increased risk of colorectal neoplasm. J Soc Colon Rectal Surgeon 19:71–77
16.
Zurück zum Zitat Delahaye F, Goulet V, Lacassin F et al (1995) Characteristics of infective endocarditis in France in 1991. A 1-year survey. Eur Heart J 16:394–401PubMed Delahaye F, Goulet V, Lacassin F et al (1995) Characteristics of infective endocarditis in France in 1991. A 1-year survey. Eur Heart J 16:394–401PubMed
17.
Zurück zum Zitat Hoen B, Alla F, Selton-Suty C et al (2002) Changing profile of infective endocarditis: results of a 1-year survey in France. JAMA 288:75–81PubMedCrossRef Hoen B, Alla F, Selton-Suty C et al (2002) Changing profile of infective endocarditis: results of a 1-year survey in France. JAMA 288:75–81PubMedCrossRef
18.
Zurück zum Zitat Selton-Suty C, Célard M, Le Moing V et al (2012) Preeminence of Staphylococcus aureus in infective endocarditis: a 1-year population-based survey. Clin Infect Dis 54:1230–1239PubMedCrossRef Selton-Suty C, Célard M, Le Moing V et al (2012) Preeminence of Staphylococcus aureus in infective endocarditis: a 1-year population-based survey. Clin Infect Dis 54:1230–1239PubMedCrossRef
19.
Zurück zum Zitat Tripodi MF, Adinolfi LE, Ragone E et al (2004) Streptococcus bovis endocarditis and its association with chronic liver disease: an underestimated risk factor. Clin Infect Dis 38:1394–1400PubMedCrossRef Tripodi MF, Adinolfi LE, Ragone E et al (2004) Streptococcus bovis endocarditis and its association with chronic liver disease: an underestimated risk factor. Clin Infect Dis 38:1394–1400PubMedCrossRef
20.
Zurück zum Zitat Hoen B, Chirouze C, Cabell CH et al (2005) Emergence of endocarditis due to group D streptococci: findings derived from the merged database of the International Collaboration on Endocarditis. Eur J Clin Microbiol Infect Dis 24:12–16PubMedCrossRef Hoen B, Chirouze C, Cabell CH et al (2005) Emergence of endocarditis due to group D streptococci: findings derived from the merged database of the International Collaboration on Endocarditis. Eur J Clin Microbiol Infect Dis 24:12–16PubMedCrossRef
21.
Zurück zum Zitat Tripodi MF, Fortunato R, Utili R et al (2005) Molecular epidemiology of Streptococcus bovis causing endocarditis and bacteraemia in Italian patients. Clin Microbial Infect 11:814–819CrossRef Tripodi MF, Fortunato R, Utili R et al (2005) Molecular epidemiology of Streptococcus bovis causing endocarditis and bacteraemia in Italian patients. Clin Microbial Infect 11:814–819CrossRef
22.
Zurück zum Zitat Giannitsioti E, Chirouze C, Bouvet A et al (2007) Characteristics and regional variations of group D streptococcal endocarditis in France. Clin Microbiol Infect 13:770–776PubMedCrossRef Giannitsioti E, Chirouze C, Bouvet A et al (2007) Characteristics and regional variations of group D streptococcal endocarditis in France. Clin Microbiol Infect 13:770–776PubMedCrossRef
23.
Zurück zum Zitat Corredoira J, Alonso MP, Coira A et al (2008) Characteristics of Streptococcus bovis endocarditis and its differences with Streptococcus viridans endocarditis. Eur J Clin Microbiol Infect Dis 27:285–291PubMedCrossRef Corredoira J, Alonso MP, Coira A et al (2008) Characteristics of Streptococcus bovis endocarditis and its differences with Streptococcus viridans endocarditis. Eur J Clin Microbiol Infect Dis 27:285–291PubMedCrossRef
25.
Zurück zum Zitat Institut de Veille Sanitaire. Bulletin épidémiologique hebdomadaire numéro thématique—dépistage organisé du cancer colorectal en France. Available online at: http://www.invs.sante.fr/beh/. Accessed 26 November 2012 Institut de Veille Sanitaire. Bulletin épidémiologique hebdomadaire numéro thématique—dépistage organisé du cancer colorectal en France. Available online at: http://​www.​invs.​sante.​fr/​beh/​. Accessed 26 November 2012
26.
Zurück zum Zitat Chauvenet M, Cottet V, Lepage C et al (2011) Trends in colorectal cancer incidence: a period and birth-cohort analysis in a well-defined French population. BMC Cancer 11:282PubMedCrossRef Chauvenet M, Cottet V, Lepage C et al (2011) Trends in colorectal cancer incidence: a period and birth-cohort analysis in a well-defined French population. BMC Cancer 11:282PubMedCrossRef
27.
Zurück zum Zitat Ferlay J, Autier P, Boniol M et al (2007) Estimates of the cancer incidence and mortality in Europe in 2006. Ann Oncol 18:581–592PubMedCrossRef Ferlay J, Autier P, Boniol M et al (2007) Estimates of the cancer incidence and mortality in Europe in 2006. Ann Oncol 18:581–592PubMedCrossRef
28.
Zurück zum Zitat Weisburg WG, Barns SM, Pelletier DA et al (1991) 16S ribosomal DNA amplification for phylogenetic study. J Bacteriol 173:697–703PubMed Weisburg WG, Barns SM, Pelletier DA et al (1991) 16S ribosomal DNA amplification for phylogenetic study. J Bacteriol 173:697–703PubMed
29.
Zurück zum Zitat Devulder G, Perrière G, Baty F et al (2003) BIBI, a bioinformatics bacterial identification tool. J Clin Microbiol 41:1785–1787PubMedCrossRef Devulder G, Perrière G, Baty F et al (2003) BIBI, a bioinformatics bacterial identification tool. J Clin Microbiol 41:1785–1787PubMedCrossRef
30.
Zurück zum Zitat Norfleet RG, Mitchell PD (1993) Streptococcus bovis does not selectively colonize colorectal cancer and polyps. J Clin Gastroenterol 17:25–28PubMedCrossRef Norfleet RG, Mitchell PD (1993) Streptococcus bovis does not selectively colonize colorectal cancer and polyps. J Clin Gastroenterol 17:25–28PubMedCrossRef
31.
Zurück zum Zitat Shanan S, Gumaa SA, Sandström G et al (2011) Significant association of Streptococcus bovis with malignant gastrointestinal diseases. Int J Microbiol 2011:792019PubMed Shanan S, Gumaa SA, Sandström G et al (2011) Significant association of Streptococcus bovis with malignant gastrointestinal diseases. Int J Microbiol 2011:792019PubMed
32.
Zurück zum Zitat Boleij A, Van Gelder MMHJ, Swinkels DW et al (2011) Clinical importance of Streptococcus gallolyticus infection among colorectal cancer patients: systematic review and meta-analysis. Clin Infect Dis 53:870–878PubMedCrossRef Boleij A, Van Gelder MMHJ, Swinkels DW et al (2011) Clinical importance of Streptococcus gallolyticus infection among colorectal cancer patients: systematic review and meta-analysis. Clin Infect Dis 53:870–878PubMedCrossRef
33.
Zurück zum Zitat Koenig JE, Spor A, Scalfone N et al (2011) Succession of microbial consortia in the developing infant gut microbiome. Proc Natl Acad Sci U S A 108:4578–4585PubMedCrossRef Koenig JE, Spor A, Scalfone N et al (2011) Succession of microbial consortia in the developing infant gut microbiome. Proc Natl Acad Sci U S A 108:4578–4585PubMedCrossRef
34.
Zurück zum Zitat Woodmansey EJ, McMurdo MET, Macfarlane GT et al (2004) Comparison of compositions and metabolic activities of fecal microbiotas in young adults and in antibiotic-treated and non-antibiotic-treated elderly subjects. Appl Environ Microbiol 70:6113–6122PubMedCrossRef Woodmansey EJ, McMurdo MET, Macfarlane GT et al (2004) Comparison of compositions and metabolic activities of fecal microbiotas in young adults and in antibiotic-treated and non-antibiotic-treated elderly subjects. Appl Environ Microbiol 70:6113–6122PubMedCrossRef
35.
Zurück zum Zitat Nam Y-D, Jung M-J, Roh SW et al (2011) Comparative analysis of Korean Human gut microbiota by barcoded pyrosequencing. PLoS One 6:e22109PubMedCrossRef Nam Y-D, Jung M-J, Roh SW et al (2011) Comparative analysis of Korean Human gut microbiota by barcoded pyrosequencing. PLoS One 6:e22109PubMedCrossRef
36.
Zurück zum Zitat De Filippo C, Cavalieri D, Di Paola M et al (2010) Impact of diet in shaping gut microbiota revealed by a comparative study in children from Europe and rural Africa. Proc Natl Acad Sci U S A 107:14691–14696PubMedCrossRef De Filippo C, Cavalieri D, Di Paola M et al (2010) Impact of diet in shaping gut microbiota revealed by a comparative study in children from Europe and rural Africa. Proc Natl Acad Sci U S A 107:14691–14696PubMedCrossRef
38.
Zurück zum Zitat Boleij A, Muytjens CMJ, Bukhari SI et al (2011) Novel clues on the specific association of Streptococcus gallolyticus subsp gallolyticus with colorectal cancer. J Infect Dis 203:1101–1109PubMedCrossRef Boleij A, Muytjens CMJ, Bukhari SI et al (2011) Novel clues on the specific association of Streptococcus gallolyticus subsp gallolyticus with colorectal cancer. J Infect Dis 203:1101–1109PubMedCrossRef
39.
Zurück zum Zitat Ellmerich S, Schöller M, Duranton B et al (2000) Promotion of intestinal carcinogenesis by Streptococcus bovis. Carcinogenesis 21:753–756PubMedCrossRef Ellmerich S, Schöller M, Duranton B et al (2000) Promotion of intestinal carcinogenesis by Streptococcus bovis. Carcinogenesis 21:753–756PubMedCrossRef
40.
Zurück zum Zitat Biarc J, Nguyen IS, Pini A et al (2004) Carcinogenic properties of proteins with pro-inflammatory activity from Streptococcus infantarius (formerly S.bovis). Carcinogenesis 25:1477–1484PubMedCrossRef Biarc J, Nguyen IS, Pini A et al (2004) Carcinogenic properties of proteins with pro-inflammatory activity from Streptococcus infantarius (formerly S.bovis). Carcinogenesis 25:1477–1484PubMedCrossRef
Metadaten
Titel
Streptococcus bovis/Streptococcus equinus complex fecal carriage, colorectal carcinoma, and infective endocarditis: a new appraisal of a complex connection
verfasst von
C. Chirouze
I. Patry
X. Duval
V. Baty
P. Tattevin
T. Aparicio
M. Pagenault
F. Carbonnel
G. Couetdic
B. Hoen
Publikationsdatum
01.09.2013
Verlag
Springer Berlin Heidelberg
Erschienen in
European Journal of Clinical Microbiology & Infectious Diseases / Ausgabe 9/2013
Print ISSN: 0934-9723
Elektronische ISSN: 1435-4373
DOI
https://doi.org/10.1007/s10096-013-1863-3

Weitere Artikel der Ausgabe 9/2013

European Journal of Clinical Microbiology & Infectious Diseases 9/2013 Zur Ausgabe

Leitlinien kompakt für die Innere Medizin

Mit medbee Pocketcards sicher entscheiden.

Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag

Echinokokkose medikamentös behandeln oder operieren?

06.05.2024 DCK 2024 Kongressbericht

Die Therapie von Echinokokkosen sollte immer in spezialisierten Zentren erfolgen. Eine symptomlose Echinokokkose kann – egal ob von Hunde- oder Fuchsbandwurm ausgelöst – konservativ erfolgen. Wenn eine Op. nötig ist, kann es sinnvoll sein, vorher Zysten zu leeren und zu desinfizieren. 

Umsetzung der POMGAT-Leitlinie läuft

03.05.2024 DCK 2024 Kongressbericht

Seit November 2023 gibt es evidenzbasierte Empfehlungen zum perioperativen Management bei gastrointestinalen Tumoren (POMGAT) auf S3-Niveau. Vieles wird schon entsprechend der Empfehlungen durchgeführt. Wo es im Alltag noch hapert, zeigt eine Umfrage in einem Klinikverbund.

Proximale Humerusfraktur: Auch 100-Jährige operieren?

01.05.2024 DCK 2024 Kongressbericht

Mit dem demographischen Wandel versorgt auch die Chirurgie immer mehr betagte Menschen. Von Entwicklungen wie Fast-Track können auch ältere Menschen profitieren und bei proximaler Humerusfraktur können selbst manche 100-Jährige noch sicher operiert werden.

Die „Zehn Gebote“ des Endokarditis-Managements

30.04.2024 Endokarditis Leitlinie kompakt

Worauf kommt es beim Management von Personen mit infektiöser Endokarditis an? Eine Kardiologin und ein Kardiologe fassen die zehn wichtigsten Punkte der neuen ESC-Leitlinie zusammen.

Update Innere Medizin

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.